Cases & Controversies in Colon Cancer Tuesday, May 3, 9:00 - 9:45 am CME Credit Hours: 0.75 This symposium focuses on cutting edge and controversial topics in the management of colon cancer. Objectives At the conclusion of this session, participants should be able to: Describe current techniques to identify which patients with stage II colon cancer would likely benefit from adjuvant chemotherapy. Compare relative benefits and risks of segmental and endoscopic resection for malignant colon polyps Identify the benefits of complete mesocolic excision for colon malignancy Agenda Co-Directors: Srinivas Joga Ivatury, MD, Lebanon, NH Virginia Shaffer, MD, Atlanta, GA Social Media Moderator: Paul Johnson, MD, Winter Park, FL 9:00 am Introduction Srinivas Joga Ivatury, MD, Lebanon, NH Virginia Shaffer, MD, Atlanta, GA 9:05 am Cases: Tailoring Adjuvant Therapy in High-Risk Stage II Colon Cancer: Use of New Diagnostic Techniques Including ctDNA Malignant Polyps – How Do You Decide? Segmental versus Endoscopic Resection Complete Mesocolic Excision and D3 Lymphadenectomy – Is there a Role in Colon Cancer? Panel: Marylise Boutros, MD, Montreal, QC, Canada Evie Carchman, MD, Madison, WI David Rosen, MD, Cleveland, OH April Roslani, MD, Kulal Lumpur, Malaysia 9:35 am Panel Discussion and Questions and Answers 9:45 am Adjourn